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Abstract
Previous studies have investigated the association between dietary inflammatory potential and the development of cancer. For breast cancer
the results have been equivocal. The present study aimed to investigate whether higher Dietary Inflammatory IndexTM (DII) scores were
associated with increased risk of breast cancer among Chinese women. A total of 867 cases and 824 controls were recruited into the present
case–control study from September 2011 to February 2016. DII scores were computed based on baseline dietary intake assessed by a validated
81-item FFQ. The OR and 95% CI were assessed by multivariable logistic regression after adjusting for various potential confounders. DII
scores in this study ranged from −5·87 (most anti-inflammatory score) to +5·71 (most proinflammatory score). A higher DII score was
associated with a higher breast cancer risk (adjusted ORquartile 4 v. 1 2·28; 95% CI 1·71, 3·03; adjusted ORcontinuous 1·40; 95%CI 1·25, 1·39). In
stratified analyses, positive associations also were observed except for underweight women or women with either oestrogen receptor+ or
progesterone receptor+ status (but not both). Results from this study indicated that higher DII scores, corresponding to more proinflammatory
diets, were positively associated with breast cancer risk among Chinese women.
Key words: Dietary Inflammatory Index: Inflammation: Breast cancer: Case–control studies
China has a low incidence of breast cancer, though since the
1990s incidence has increased more than twice as fast as have
the global rates(1). According to cancer statistics for China in
2015, breast cancer alone is expected to account for 15% of all
new cancers in women and is the leading cause of cancer death
in women younger than 45 years(2). Although acute inflamma-
tory response is needed for mounting a normal immune
response, chronic inflammation is known to be associated with
common epithelial cancers, including breast cancer(3). Although
dietary factors have been shown to be related to chronic
inflammatory states, which play an important role in breast
cancer development, there is little evidence of the proin-
flammatory and anti-inflammatory effects of the overall diet on
breast cancer risk(4,5).
It is known that mediators and cellular effectors of inflamma-
tion are important constituents of the tumour microenviron-
ment(6). Inflammation has been suggested as an important player
in breast cancer initiation, promotion and metastasis, all phases in
Abbreviations: CRP, C-reactive protein; DII, Dietary Inflammatory Index; ER, oestrogen receptor; PR, progesterone receptor.
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which cytokines are prominent players(7). A number of studies
indicate that the levels of inflammatory cytokines, particularly
C-reactive protein (CRP), are associated with breast cancer
development(8–10). CRP is a classical acute phase reactant protein
from the pentraxin family; and a moderate rise in CRP level is
seen in chronic inflammatory states(11). IL-6 is involved in the
Stat3 pathway, which results in the induction of carboxylic acid
terminal functional group and increased expression of fascin,
both of which play an important role in breast cancer cell
migration and invasion(12).
To date, the association between diet and inflammatory states
has been explored with respect to foods, nutrients and dietary
patterns. For instance, fibre, PUFA, vitamin C/E, fruit and
vegetable intake, Mediterranean diet pattern and low-glycaemic
index diet are associated with lower levels of chronic inflam-
mation(4,5,13–16). In contrast, red meat and butter intake, SFA
and a Western dietary pattern appear to increase levels of high-
sensitivity CRP (hs-CRP) and proinflammatory interleukins
which are used as markers of inflammation(4,5,17).
The Dietary Inflammatory IndexTM (DII), originally devel-
oped by Cavicchia et al.(18) and updated by Shivappa et al.(19)
in 2014 at the University of South Carolina, is a literature review-
based score that reflects the potential inflammatory effects of
the diet. Previous studies have been performed to evaluate the
associations between the DII score and cancer risk, including
colorectal cancer, ovarian cancer and breast cancer(20–32). To
date, six studies drawing mixed conclusions have been con-
ducted to investigate the association between DII scores and
breast cancer risk in Europe and the USA(27–32). In addition, no
study has been performed in Asia, where dietary patterns are
different from those of Europe and North America.
The aim of the present study was to investigate whether
individual diets based on their inflammatory potential effects, as
indicated by their DII scores, were associated with breast cancer
risk. Our hypothesis was that a higher DII score (indicating a
proinflammatory diet) increases the risk of breast cancer.
Methods
Study subjects
This is an ongoing case–control study begun in September
2011. Potential cases were recruited among patients who were
admitted to the surgical units of three teaching and general
hospitals in Guangzhou, China from September 2011 to
February 2016. Eligible subjects were female, aged 25–70 years
and natives of the province of Guangdong or having lived in
Guangdong for at least 5 years, with incident, primary,
histologically confirmed breast cancer diagnosed no more than
3 months before the interview. Women were excluded if they
could not understand or speak Mandarin/Cantonese or had a
prior history of breast cancer or other cancers. A total of 867
cases out of 955 eligible women (90·8%) participated in
this study.
Controls were patients with no history of cancer and admitted
to the same hospitals during the same time period as the cases.
They were frequency matched by age (5-year interval) to the
case patients. They were selected from the departments of
Ophthalmology, Plastic and Reconstructive Surgery, Vascular
Surgery, Ear-Nose-Throat and Orthopaedics and Microsurgery.
A total of 824 (91·6%) controls out of 900 eligible controls
participated in this study.
We assumed that people with higher DII score represented
25% of the general population, the estimated OR between the
DII score and breast cancer risk was 1·41(11), the type I error
rate was <0·05 (α= 0·05), the power of test was 80% (β= 0·20)
and the response rate was 90%. Based on these assumptions,
we require a sample size of 762 cases.
The present study was conducted according to the guidelines
laid down in the Declaration of Helsinki. All procedures
involving human subjects were approved by the ethical com-
mittee of School of Public Health, Sun Yat-sen University.
Written informed consent was obtained from all participants
before the interview.
Data collection
All study participants completed a face-to-face interview
conducted by trained interviewers using a structured ques-
tionnaire to collect information on dietary habits and potential
confounding factors.
The core questionnaire was used to collect information on
socio-demographic factors, body weight and height, lifestyle
factors (e.g. active and passive smoking, alcohol drinking and
physical activity), menopausal status and reproductive history
and family history of cancer. In this study, regular smokers were
defined as someone smoking at least one cigarette a day for
more than 6 consecutive months. Passive smoking meant to be
exposed to others’ tobacco smoke for at least 5min/d in the
previous 5 years. Regular drinking was defined as alcohol
drinking at least once per week in the past year.
Postmenopausal status was defined as at least 12 months since
the last menstrual cycle. BMI was calculated by dividing weight
(kg) by height (m2) squared. In addition, leisure-time physical
activity was measured. Relevant medical information, medical
diagnosis, histological findings and oestrogen receptor (ER) and
progesterone receptor (PR) status were abstracted from the
hospital medical records.
An 81-item FFQ was used to collect data on food consump-
tion. Participants were asked to report information on
frequency of intake and portion size during the preceding
12 months before diagnosis for cases or interview for controls.
From these data the average intake of each food item in g/d
were calculated. Food photographs were used to help partici-
pants quantify the portions consumed. Information on
frequency of intake and portion size was used to calculate the
amount of each food item consumed on average (g/d). Total
energy and intakes of specific nutrients were computed based
on the 2002 Chinese Food Composition Table(33).
Calculation of the Dietary Inflammatory Index score
The original DII was developed by Cavicchia et al.(18) and
updated by Shivappa et al.(19) and the calculation process was
documented elsewhere. Hs-CRP measurements were used to
examine construct validity of the DII in a longitudinal cohort








bridge.org/core . IP address: 71.70.64.242 , on 26 Jun 2020 at 01:03:43 , subject to the Cam
bridge Core term






using DII scores derived from 24-h dietary recall interviews and
7-d dietary recalls. In the updated version, 1943 articles were
reviewed and scored. In all, forty-five food parameters,
including foods, nutrients and other bioactive compounds,
were evaluated based on their inflammatory effect on six
specific inflammatory markers, such as CRP, IL-1β, IL-4, IL-6,
IL-10 and TNF-α. A world database based on food consumption
from eleven populations globally represented global daily
intake for each of the forty-five parameters (i.e. foods, nutrients
and other food components). This was used as standard dietary
intake reference to standardise DII scores to global norms.
A standard mean for each parameter from the representative
world database was subtracted from the actual individual
exposure and divided by its standard deviation to generate
z scores. These z scores were converted to percentiles
(minimising effects of outliers/right- skewing), then doubled the
value and subtracted 1 to achieve symmetrical distribution with
values centred on 0. The resulting value was then multiplied by
the corresponding inflammatory score for each food parameter
and summed across all food parameters, in order to obtain the
overall DII score. The inflammatory score for each food
parameter derived from a literature review on the basis of 1943
articles representing studies of different design on diet and
inflammation. Overall, thirty-three of the forty-five possible
food parameters used for the DII calculation were available in
this study, and these food parameters were vitamin B12,
vitamin B6, β-carotene, carbohydrate, cholesterol, fat, fibre, folic
acid, garlic, Fe, Mg, MUFA, niacin, n-3 fatty acids, n-6 fatty
acids, onion, protein, PUFA, riboflavin, SFA, Se, thiamin, vita-
min A, vitamin C, vitamin E, Zn, flavan-3-ol, flavones, flavonols,
anthocyanidins, isoflavones and pepper. We calculated the DII
score based on energy-adjusted intake of the thirty-three single
food parameters using the energy density approach which
calculated per 4184 kJ (1000 kcal) of energy(34). As the original
construct validation, the new DII also was validated in four
studies in different populations with an extended number of
inflammatory biomarkers (e.g. IL-6, hs-CRP, and TNF-α)(35–38).
Statistical analysis
The DII score was categorised into quartiles based on the
distribution among the controls. The DII was analysed both as a
continuous variable (i.e. a one-unit increment in the DII
corresponds to approximately 12% of its global range) and by
quartiles of exposure. The lowest quartile of DII scores served
as the reference group in the analyses. Student’s t test, one-way
ANOVA test and Kruskal–Wallis tests were used for continuous
variables and χ2 test were used for categorical variables to test
differences between different groups. OR and 95% CI
summarising the association between breast cancer risk and the
DII score were calculated by using unconditional logistic
regression. The following variables were adjusted in the logistic
regression models: education, income, passive smoking, BMI,
first-degree relative with cancer and history of benign breast
disease. Confounding factors were selected by comparing
baseline characteristics between the cases and controls. Tests
for trend were performed by entering the categorical variables
as continuous parameters in the models.
In China, BMI< 18·5 kg/m2 was defined as underweight,
BMI≥ 18·5 and <24kg/m2 as normal weight, BMI≥ 24 and
<28kg/m2 as overweight and BMI≥ 28kg/m2 as obese(39).
Analyses stratified by BMI (underweight, normal weight, over-
weight and obese) were conducted. Moreover, stratified analyses
by menopausal status (premenopausal and postmenopausal)
and sex hormone status (ER-positive (ER+), or ER-negative
(ER−); PR-positive (PR+) or PR-negative (PR−)) also were
conducted. The significance level was set at 0·05 (two-sided). All
of the aforementioned statistical analyses were performed using
SPSS® 13.0 (SPSS Inc.).
Results
The comparison of baseline characteristics between cases and
controls is shown in Table 1. Compared with controls, breast
cancer cases were more likely to have lower levels of education
and income. Compared with controls, more cases reported
having a first-degree relative with cancer, a history of benign
breast disease and a higher BMI. A higher proportion of cases
tended to smoke regularly and be exposed to second-hand
smoke. All of the above-referenced variables were considered
potential confounders and adjusted for in the subsequent
multivariable analyses. No significant differences were observed
between cases and controls on age, occupation, marital status,
physical activity, alcohol drinking, age at menarche, age at first
live birth, menopausal status, parity, breast-feeding history, ever
use of oral contraceptive or hormone replacement therapy.
The DII score in this study ranged from −5·87 (most anti-
inflammatory score) to +5·71 (most proinflammatory score) and
the mean DII score −1·48 (SD 1·78). For cases, the mean DII was
−1·75 (SD 1·66), and it was −1·23 (SD 1·86) for controls. Intakes of
thirty-three dietary nutrients available in the calculation of DII are
presented in Table 2. A higher DII score was significantly asso-
ciated with higher intake of SFA and distributions of some
nutrients (total fat, folic acid, Fe, n-6 fatty acids, PUFA, vitamin A)
were significantly different across quartiles of DII score. Total fat
intake in the 3rd quartile of DII score was lower than that
observed in any other quartile; the highest folic acid intake was
in the 2nd quartile, whereas the lowest intake was observed in
the 3rd quartile. The highest vitamin A intake was in the 2nd
quartile, whereas the lowest intake was in the 4th quartile. Fe
intake in the 4th quartile was the lowest and medians of intake in
other quartiles were equal, which was the same distribution as
PUFA; n-6 fatty acid intake was highest in the 4th quartile.
More control subjects in the 1st quartile of DII scores were
exposed to passive smoking than in any other quartile. More
case subjects in the 4th quartile of DII score had a first-degree
relative with cancer than observed in any other quartile. All
other distributions of characteristics among case or control
subjects were not significantly different across quartiles of DII
(online Supplementary Tables S1 and S2).
The association between the DII and breast cancer risk is
shown in Table 3. When analyses were carried out using con-
tinuous DII, a significant positive association between breast
cancer risk and the DII score was observed (crude OR 1·36;
95% CI 1·23, 1·51; adjusted OR 1·40; 95% CI 1·25, 1·39). When
fitted as quartiles, there was a trend of increasing risk for
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increasing levels of the DII. The crude OR was 2·08 (95% CI
1·59, 2·73) comparing the highest with the lowest quartile
(Ptrend< 0·001). After adjusting for potential confounding
factors, the association remained significant, with an adjusted
OR for the highest quartile compared with the lowest of 2·28
(95% CI 1·71, 3·03) (Ptrend< 0·001).
The results of stratified analyses also are shown in Table 3.
Totally, there were 1094 premenopausal women (561 cases and
533 controls) and 597 postmenopausal women (306 controls
and 291 cases). A proinflammatory diet was found to increase
the risk of breast cancer in both premenopausal and post-
menopausal women (highest v. lowest quartile: adjusted OR
2·60 among premenopausal women; 95% CI 1·81, 3·78,
Ptrend< 0·001; adjusted OR 1·89 among postmenopausal
women; 95% CI 1·17, 3·06, Ptrend= 0·005).
When cases were stratified based on ER and PR status, 414
cases were in ER+ and PR+ stratum, seventy-one cases in ER+
or PR+ stratum and 194 cases in ER− and PR− status.
Table 1. Characteristics data of breast cancer cases and matched controls in a Chinese case–control study,
2011–2016
(Mean values and standard deviations; numbers and percentages)
Cases (n 867) Controls (n 824)
Variables Mean SD Mean SD P
Age (years) 47·2 9·7 46·9 10·1 0·43
BMI (kg/m2) 23·1 3·3 22·6 3·1 <0·01
Age at menarche (years) 14·5 1·9 14·6 1·7 0·22
Age at first live birth (years)* 25·7 3·7 25·5 3·2 0·33
DII score −1·8 1·7 −1·2 1·9 <0·01
n % n %
Marital status 0·64
Married 819 94·5 774 93·9
Unmarried/divorced/widowed 48 5·5 50 6·1
Education level <0·01
Primary school or below 218 25·1 218 26·5
Junior high school 260 30·0 188 22·8
Senior high school/secondary technical school 318 36·7 293 35·6
College or above 71 8·2 125 15·2
Occupation 0·36
Blue collar worker 249 28·7 220 26·7
Administrator/other white collar worker 164 18·9 177 21·5
Farmer/other 454 52·4 427 51·8
Income level (yuan/month) <0·01
<2000 125 14·4 49 5·9
2001–5000 258 29·8 186 22·6
5001–8000 281 32·4 303 36·8
>8001 203 23·4 286 34·7
Physical activity (exercise for health) 0·44
Never 375 43·3 319 38·7
Seldom 59 6·8 35 4·2
Often 433 49·9 470 57·0
Regular smoker 14 1·6 12 1·5 0·71
Passive smoking 563 64·9 428 51·9 <0·01
Regular drinker 68 7·8 52 6·3 0·22
Menopausal status 0·99
Premenopausal 561 64·7 533 64·7
Postmenopausal 306 35·3 291 35·3
Breast-feeding history† 728 84·0 683 82·9 0·84
Parity 0·19
0 39 4·5 39 4·7
1–2 637 73·5 633 76·8
≥3 191 22·0 152 18·4
First-degree relative with cancer 127 14·6 75 9·1 <0·01
History of benign breast disease 307 35·4 205 24·9 <0·01
Ever used an oral contraceptive 65 7·5 45 5·5 0·09
Hormone replacement therapy use 31 3·6 26 3·2 0·63
Hormonal receptor status‡
ER+ and PR+ 417 48·1
ER+ or PR+ (but not both) 71 8·2
ER− and PR− 194 22·4
DII, Dietary Inflammatory Index; ER, oestrogen receptor; PR, progesterone receptor.
* Among women who had a live birth.
† Among breast-feeding women.
‡ Among cases.
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Compared with the lowest quartile, both the 3rd and 4th
quartiles of the DII score were positively associated with ER+
and PR+ breast cancer (adjusted OR 1·76; 95% CI 1·20, 2·56;
adjusted OR 2·81; 95% CI 1·96, 4·03; Ptrend< 0·001). Among
women with ER+ or PR+ status (but not both), the OR com-
paring the highest quartile with the lowest quartile was not
significant. We also observed a positive association of breast
cancer with DII scores in the ER− and PR− subtype (adjusted
OR 2·13; 95% CI 1·35, 3·49; Ptrend< 0·001).
In this study, 110 women (forty-eight cases and sixty-two
controls) were underweight, 1047 (531 cases and 516 controls)
were within normal weight, 427 (223 cases and 204 controls)
were overweight and 107 (sixty-five cases and forty-two
controls) were obese. Positive associations between DII score
and breast cancer were found among normal weight, over-
weight and obese women (highest v. lowest quartile: adjusted
OR 1·97 among normal weight women; 95% CI 1·37, 2·81,
Ptrend< 0·001; adjusted OR 2·60 among overweight women;
95% CI 1·47, 4·57, Ptrend= 0·001; adjusted OR 4·96 among obese
women; 95% CI 1·35, 18·23, Ptrend= 0·008), but no association
was found among underweight women.
The correlation coefficients between each of the food para-
meters comprising the DII were calculated. The results showed
that several components of DII were correlated with each other
(online Supplementary Table S3). Some food parameters were
strongly correlated, such as β-carotene and vitamin C (correla-
tion coefficient= 0·89). Some were weakly correlated such as
garlic and thiamin (correlation coefficient= 0·01).
Discussion
In this case–control study, a positive association was found
between a higher DII score (corresponding to a proinflammatory
diet) and breast cancer risk among Chinese women. We also
observed that higher DII scores were related to increased risk of
breast cancer among women with ER+ and PR+ status and
ER− and PR− status but not women with either ER+ or PR+ status
(but not both). When stratified by BMI, positive associations
between DII and breast cancer were observed among normal
weight, overweight and obese women but not among under-
weight women. In addition, the results of stratification analyses
indicated that the inflammatory effect of diet on breast cancer was
independent of menopausal status.
Chronic inflammation is a key contributor in the development
and progression of carcinogenesis(6). Inflammatory pathways play
an important role in the causation of breast cancer(40). Some risk
factors for breast cancer (age, obesity, menopause and diet) are
associated with systemic inflammation, as indicated by increased
Table 2. Nutrition data across quartiles (Q) of the Dietary Inflammatory Index score in a Chinese case–control study, 2011–2016
(Medians and 25th, 75th percentiles)
Overall inflammatory
Q1 Q2 Q3 Q4
Variables effect score Median P25, P75 Median P25, P75 Median P25, P75 Median P25, P75 P
Vitamin B12 (mg/d) 0·106 2 1, 2 2 1, 3 2 1, 2 2 1, 3 0·46
Vitamin B6 (mg/d) −0·365 1 1, 1 1 1, 1 1 1, 1 1 1, 1 0·84
β-Carotene (mg/d) −0·584 3650 2663, 4800 3736 2842, 4754 3615 2619, 4607 3381 2500, 4754 0·09
Carbohydrate (g/d) 0·097 213 182, 256 218 186, 261 213 187, 254 215 187, 261 0·68
Cholesterol (mg/d) 0·11 304 227, 407 311 211, 417 285 204, 376 292 201, 417 0·04
Total fat (g/d) 0·298 57 43, 75 57 42, 72 52 42, 68 57 44, 72 0·04
Fibre (g/d) −0·663 9 7, 11 9 7, 10 8 7, 11 9 7, 10 0·61
Folic acid (μg/d) −0·19 206 170, 256 209 175, 250 198 165, 240 203 165, 250 0·04
Garlic (g/d) −0·412 0 0, 2 0 0, 2 1 0, 2 1 0, 2 0·67
Fe (mg/d) 0·032 17 15, 20 17 15, 20 17 14, 20 16 14, 20 0·04
Mg (mg/d) −0·484 248 210, 292 245 207, 289 240 199, 281 239 200, 289 0·1
MUFA (g/d) −0·009 21 16, 28 20 16, 28 20 16, 28 23 17, 28 <0·01
Niacin (mg/d) −0·246 15 12, 18 15 12, 18 14 12, 17 14 12, 18 0·08
n-3 Fatty acids (g/d) −0·436 1 1, 1 1 1, 2 1 1, 1 1 1, 2 0·16
n-6 Fatty acids (g/d) −0·159 12 9, 17 12 9, 16 12 9, 17 13 10, 16 0·02
Onion (g/d) −0·49 1 0, 5 1 0, 5 1 0, 5 1 0, 5 0·68
Protein (g/d) 0·021 64 53, 76 64 54, 75 62 50, 74 62 52, 75 0·17
PUFA (g/d) −0·337 12 9, 17 12 9, 17 12 9, 17 13 10, 17 0·01
Riboflavin (mg/d) −0·068 1 1, 1 1 1, 1 1 1, 1 1 1, 1 0·73
SFA (g/d) 0·373 13 10, 17 13 10, 17 12 10, 18 14 10, 17 0·01
Se (mg/d) −0·191 41 32, 56 42 31, 56 39 31, 51 41 30, 56 0·15
Thiamin (mg/d) −0·098 1 1, 1 1 1, 1 1 1, 1 1 1, 1 0·21
Vitamin A (RE/d) −0·401 791 590, 1037 798 603, 1014 766 560, 965 727 546, 1014 0·02
Vitamin C (mg/d) −0·424 143 99, 191 149 114, 183 143 102, 180 134 100, 183 0·06
Vitamin E (mg/d) −0·419 10 8, 13 10 8, 13 10 8, 12 10 8, 13 0·23
Zn (mg/d) −0·313 8 7, 9 8 7, 10 8 6, 9 8 7, 10 0·48
Flavan-3-ol (mg/d) −0·415 6 3, 10 6 3, 11 6 4, 10 6 3, 11 0·65
Flavones (mg/d) −0·616 5 3, 9 6 3, 9 5 3, 8 6 3, 9 0·44
Flavonols (mg/d) −0·467 27 19, 38 28 21, 37 27 19, 36 26 18, 37 0·08
Flavonones (mg/d) −0·25 3 2, 5 3 2, 5 3 2, 5 3 2, 5 0·45
Anthocyanidins (mg/d) −0·131 16 10, 25 16 11, 25 16 10, 25 17 10, 25 0·74
Isoflavones (mg/d) −0·593 7 3, 12 7 3, 11 5 3, 10 6 2, 11 0·08
Pepper (g/d) −0·397 0 0, 4 0 0, 5 0 0, 5 0 0, 5 0·52
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Table 3. Dietary Inflammatory Index (DII) score and breast cancer risk in a Chinese case–control study, 2011–2016
(Mean values and standard deviations; odds ratios and 95% confidence intervals)
Q1 Q2 Q3 Q4 Continuous
Variables OR 95% CI OR 95% CI OR 95% CI OR 95% CI Ptrend* OR 95% CI P
Overall
Cases/controls (n) 162/205 159/207 210/208 336/204 867/824
DII score
Mean −3·58 −2·45 −1·50 0·61 −1·48
SD 0·61 0·20 0·32 1·24 1·78
Crude OR 1 0·97 0·73, 1·30 1·28 0·96, 1·69 2·08 1·59, 2·73 <0·001 1·36 1·23, 1·51 <0·001
Adjusted OR† 1 1·01 0·75, 1·38 1·42 1·05, 1·91 2·28 1·71, 3·03 <0·001 1·40 1·25, 1·39 <0·001
Menopausal status
Premenopausal
Cases/controls (n) 103/135 103/138 143/133 212/127 561/533
DII score
Mean −3·60 −2·45 −1·50 0·59 −1·52
SD 0·62 0·25 0·32 1·21 1·76
Crude OR 1 0·98 0·68, 1·40 1·41 0·99, 2·00 2·19 1·56, 3·07 <0·001 1·39 1·22, 1·59 <0·001
Adjusted OR† 1 0·95 0·64, 1·41 1·59 1·08, 2·31 2·60 1·81, 3·78 <0·001 1·50 1·30, 1·73 <0·001
Postmenopausal
Cases/controls (n) 59/70 56/69 67/75 124/77 306/291
DII score
Mean −3·55 −2·44 −1·50 0·66 −1·42
SD 0·57 0·25 0·32 1·30 1·83
Crude OR 1 0·96 0·59, 1·58 1·06 0·66, 1·71 1·91 1·22, 2·99 0·002 1·28 1·15, 1·41 0·002
Adjusted OR† 1 1·09 0·64, 1·83 1·23 0·74, 2·06 1·89 1·17, 3·06 0·005 1·27 1·06, 1·53 0·01
Sex hormone status
ER+ and PR+
Cases/controls (n) 66/205 74/207 108/208 169/204 417/824
DII score
Mean −3·56 −2·45 −1·52 0·64 −1·53
SD 0·59 0·25 0·32 1·24 1·76
Crude OR 1 1·11 0·76, 1·63 1·61 1·12, 2·32 2·57 1·82, 3·63 <0·001 1·48 1·30, 1·68 <0·001
Adjusted OR† 1 1·17 0·79, 1·75 1·76 1·20, 2·56 2·81 1·96, 4·03 <0·001 1·50 1·31, 1·72 <0·001
ER+ or PR+
Cases/controls (n) 16/205 10/207 17/208 28/204 71/824
DII score
Mean −3·55 −2·45 −1·54 0·55 −1·71
SD 0·58 0·25 0·32 1·23 1·68
Crude OR 1 0·62 0·27, 1·40 1·05 0·52, 2·13 1·76 0·92, 3·35 0·030 1·36 1·05, 1·76 0·02
Adjusted OR† 1 0·62 0·26, 1·44 1·09 0·52, 2·30 1·91 0·97, 3·80 0·022 1·41 1·07, 1·86 0·015
ER− and PR−
Cases/controls (n) 41/205 36/207 36/208 81/204 194/824
DII score
Mean −3·56 −2·45 −1·51 0·56 −1·65
SD 0·60 0·25 0·32 1·29 1·73
Crude OR 1 0·87 0·53, 1·42 0·87 0·53, 1·41 1·99 1·30, 3·03 0·001 1·36 1·15, 1·60 <0·001
Adjusted OR† 1 0·93 0·56, 1·55 0·91 0·54, 1·52 2·13 1·35, 3·49 0·001 1·35 1·14, 1·61 0·001
BMI (kg/m2)
Underweight (<18·5)
Cases/controls (n) 7/14 7/12 14/19 20/17 48/62
DII score
Mean −3·5 −2·43 −1·55 0·26 −1·52
SD 0·51 0·26 0·3 1·19 1·76
Crude OR 1 1·17 0·32, 4·28 1·47 0·47, 4·61 2·35 0·77, 7·17 0·103 1·52 0·96, 2·42 0·08
Adjusted OR† 1 1·32 0·27, 6·45 1·39 0·33, 5·91 3·80 0·93, 15·63 0·060 1·76 0·99, 3·13 0·06
Normal weight (≥18·5 and <24)
Cases/controls (n) 107/121 94/135 120/130 210/130 531/516
DII score
Mean −3·61 −2·45 −1·51 0·67 −1·47
SD 0·64 0·24 0·33 1·22 1·82
Crude OR 1 0·79 0·54, 1·14 1·04 0·73, 1·50 1·83 1·30, 2·57 <0·001 1·32 1·16, 1·50 <0·001
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levels of circulating proinflammatory cytokines(41–45). Effects
of diet and dietary components on inflammation have been
identified(4,46–48). However, little evidence exists on the proin-
flammatory and anti-inflammatory effects of the overall diet on
breast cancer risk. The DII was developed and refined to quantify
the inflammatory potential of individual diets based on the
literature that assessed each food parameter having a positive
or negative effect on inflammation(19). For example, consistent
with prior research linking SFA intake to increased inflamma-
tion(4), the overall inflammatory score for SFA used in the DII
calculation process is 0·373. This high score represents a strong
proinflammatory effect. The DII has been used to evaluate
the inflammatory effects of diet on the incidence of various
diseases, including CVD, the metabolic syndrome and various
cancers(20–32,49–51).
To date, there have been two case–control studies and four
prospective studies investigating the inflammatory effects of
diet on breast cancer risk(27–32). Consistent with the findings of
the current study, one case–control and two prospective studies
produced results consistent with a proinflammatory diet
increasing the risk of breast cancer(28–30). However, a recent
study based on data from the Women’s Health Initiative, the DII
was not associated with incidence of overall breast cancer;
though increasing DII score was associated with a higher risk of
death from breast cancer(31). Consistent with this null result, no
association was observed in a case–control study conducted in
Germany among postmenopausal women(27). Also the analysis
based on the Women’s Health Initiative found that a history of
proinflammatory diets or sustained intake of highly proin-
flammatory diets may be associated with a higher risk of
developing the ER− , PR− , HER2+ subtype of breast cancer(32).
Results from previous studies on the association between the
DII score and breast cancer based on menopausal status have
been mixed. A previous prospective study conducted in
Sweden found that a higher DII score increased the risk of
breast cancer, most convincingly among postmenopausal
women(30). Another recent prospective study using data from
the Iowa Women’s Health Study also observed that a proin-
flammatory diet appears to increase the risk of developing
breast cancer in postmenopausal women(28). However, no
significant association was observed among postmenopausal
women in the German case–control study(27). In the present
study, the DII score was positively associated with breast cancer
risk in both premenopausal and postmenopausal women.
We found that a higher DII score was associated with greater
breast cancer in women with both hormone receptor (ER and
PR)-positive or hormone receptor-negative status, but not sig-
nificantly in women with just ER+ or PR+ alone. A key down-
stream mediator of proinflammatory cytokines is the NF-κB
family of transcription factors, which is known to play a critical
role in the development and progression of a variety of
tumours(52). Previous studies have found NF-κB activation
to be predominantly associated with ER− breast tumours(53).
However, there is an increasing amount of evidence that NF-κB
activation occurs in ER+ tumours(54). The cause of NF-κB acti-
vation is largely unknown, but the status of PR, which has been
shown to have an anti-inflammatory role in breast cancer cells,
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there is different dietary inflammatory effect on the risk of breast
cancer subtypes according to different hormone receptor status.
This is an area requiring more intensive research.
Compared with the association among women within normal
weight, a stronger positive association between the DII score and
breast cancer was observed among overweight and obese women
in the present study; however, no significant association was
found for underweight women. This finding is consistent with the
idea that overweight or obese women are more sensitive to
the effects of inflammatory stimuli(41). One likely explanation for
the tight link between obesity, inflammation and breast cancer can
be explained by the recruitment of macrophages into adipose
tissue, where they form characteristic ‘crown-like’ structures
around apoptotic adipocytes. Macrophages and adipocytes are
able to produce inflammatory factors, such as adipokines
and cytokines, leading to activation of the proinflammatory
transcription factor NF-κB in adipose tissue and liver(54). The other
reasonable explanation may be the observation that adipocytes
express aromatase and that this enzyme is up-regulated in
the adipose tissue of obese women resulting in elevated sex-
hormones biosynthesis. Aromatase expression is regulated not
only by PG but also by proinflammatory cytokines(56). However,
underweight women had less adipose tissue and the less apoptotic
adipocytes and aromatase expression. The inflammatory effect of
diet may be too weak to make a difference in the development
of breast cancer for underweight women who are less sensitive to
the effects of inflammation(41).
The strengths of this study are the relatively large sample, the
satisfactory reproducibility and the reasonable validity of the
81-item FFQ(57). In addition, to the best of our knowledge, this
is the first study to investigate the association of inflammatory
effects of diet with breast cancer by the DII in China. Despite its
strengths, some limitations should be acknowledged. First,
although most of the forty-five DII variables were taken into
account (n 33), some items (n 12) were not available for the
DII calculation, such as alcohol, caffeine, eugenol, saffron,
green tea, vitamin D ginger, turmeric, thyme or oregano,
rosemary (anti-inflammatory factors) and trans-fat acids
(proinflammatory factor) that were usually consumed in small
amounts, infrequently, or not consumed at all in the Chinese
women; thus, they may not have had a major impact on the
scoring. Second, selection bias and recall bias are inevitable in
hospital-based case–control studies. To minimise selection bias,
all control subjects were carefully recruited to exclude any
diagnosis potentially related either to breast cancer or dietary
changes. The time-concordant period of hospitalisation and
identical catchment areas of all subjects, and the relatively high
response rate also helped to reduce selection bias. In addition,
to minimise recall bias, cases were interviewed as soon as the
diagnosis was made. In addition, in the present study, greater
effort was invested in interviewing cases before their surgery.
Moreover, food photographs were provided to assist partici-
pants with quantification of dietary intake. Third, in the present
study, the controls were recruited from the hospitals. The
participant referrals had a higher proportion of more highly
educated women than that of the general population(58). As
such, the participants might have different dietary habits; and
maybe have been able to provide more accurate responses to
questionnaires. Therefore, generalising the findings in this study
should be made with caution. Fourth, there also were potential
confounders that we were unable to measure, and therefore,
residual confounding might also remain even though various
dietary and non-dietary confounders were adjusted. However,
potential confounding bias may be minimised by adjusting for a
wide range of known confounding factors, such as income,
BMI, family history of breast cancer and history of benign breast
disease. Fifth, because CRP or other inflammation parameters in
blood levels were not measured in the present study, we cannot
evaluate how much of the variation of inflammatory markers
could be explained by the DII. Further studies are needed to
clarify this association. Sixth, we did observe collinearity
between intake values of various food parameters which is
integral to any dietary pattern and diet score.
In conclusion, compared with women who consumed an anti-
inflammatory diet, women who consumed a more proin-
flammatory diet appeared to be at increased risk of breast cancer,
especially overweight and obese women (i.e. with BMI>24kg/m2)
and women with ER+ and PR+ status and ER− and PR− status.
Further studies are needed to investigate the mutual relationships
between the inflammatory effect of diet, circulation cytokines
levels and the risk of developing breast cancer.
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